STATUS OF PLASMA ELECTROLYTES, UREA, CREATININE, AND C-REACTIVE PROTEIN IN CANCER PATIENTS.

Olubunmi C Ojo; Modupe F Asaolu; Ajibade O Oyeyemi; Ibikunle Akinlua; Olorunfemi M Molehin; Olufisayo G Oyebanji

doi:10.22159/ajpcr.2018.v11i1.22033

Authors

Olubunmi C Ojo Department of Biochemistry, Faculty of Science, Ekiti State University Ado-Ekiti, P.M.B. 5363 Ado-Ekiti, Nigeria.
Modupe F Asaolu Department of Biochemistry, Faculty of Science, Ekiti State University Ado-Ekiti, P.M.B. 5363 Ado-Ekiti, Nigeria.
Ajibade O Oyeyemi Department of Biochemistry, Faculty of Science, Ekiti State University Ado-Ekiti, P.M.B. 5363 Ado-Ekiti, Nigeria.
Ibikunle Akinlua Department of Biochemistry, Faculty of Science, Ekiti State University Ado-Ekiti, P.M.B. 5363 Ado-Ekiti, Nigeria.
Olorunfemi M Molehin Department of Biochemistry, Faculty of Science, Ekiti State University Ado-Ekiti, P.M.B. 5363 Ado-Ekiti, Nigeria.
Olufisayo G Oyebanji Department of Biochemistry, Faculty of Science, Ekiti State University Ado-Ekiti, P.M.B. 5363 Ado-Ekiti, Nigeria.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i1.22033

Keywords:

Electrolytes, Urea, Creatinine, C-reactive protein, Cancer

Abstract

Â Objective: Cancer is a major health problem not only in developed countries but also in developing countries like Nigeria. This study was designed to study the status of plasma electrolytes, urea, creatinine, and C-reative proteins (CRPs) in freshly diagnosed cancer patients.

Methods: Plasma electrolytes (sodium [Na+], potassium [K+], chlorine [Cl-], and bicarbonate [HCO3-]), urea, creatinine, and CRP were estimated in four different types of cancer (liver, colon, cervical, and uterine) patients attending Ekiti State University Teaching Hospital Ado Ekiti Nigeria. A total of 250 patients (between age of 45 and 70 years) consisting of 50 patients in each cancer type and 50 normal subjects as control were considered in this study.

Results: The result obtained revealed a significant (p<0.05) increase in the plasma levels of Na+, Cl-, creatinine, and CRP in all the cancer types when compared with the control subjects. Plasma urea level decreased significantly in patients with colon (3.16Â±0.70 mmol/L) and liver (3.03Â±1.75 mmol/L) cancer when compared with the control subjects (4.80Â±1.12 mmol/L). K+ and HCO3_ level was not significantly (p>0.05) different in all cancer types when compared with the control subjects.

Conclusion: This study revealed a possible link between plasma electrolytes, creatinine, CRP, urea, and cancer which could be useful in the assessment and management of cancer.

Downloads

Download data is not yet available.

References

Sylla BS, Wild CP. A million Africans a year dying from cancer by 2030: What can cancer research and control offer to the continent? Int J Cancer 2012;130:245-50.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.

Boyle P, Levin B. World Cancer Report 2008. Lyon, France: International Agency for Research on Cancer; 2008.

Lyerly HK, Abernethy AP, Stockler MR, Koczwara B, Aziz Z, Nair R, et al. Need for global partnership in cancer care: Perceptions of cancer care researchers attending the 2010 Australia and Asia pacific clinical oncology research development workshop. J Oncol Pract 2011;7:324-9.

Anand P, Kunnumakkara AB, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008;25:2097-116.

Gupta M, Dahiya J, Marwaha RK, Dureja H. Therapies in cancer treatment: An overview. Int J Pharm Pharm Sci 2015;7:1-9.

Pramila P, Abraham A, Pawar S, Bafna V, Bansal MS. To study the therapeutic management, drug related problems and concomitant use of drugs in patients with cancer. Int J Pharm Pharm Sci 2017;9:139-44.

Yadav AS, Khodke PV. Status of serum electrolytes in cancer patients. Int J Basic Appl Med Sci 2015;5:208-11.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.

Filippatos TD, Milionis HJ, Elisaf MS. Alterations in electrolyte equilibrium in patients with acute leukemia. Eur J Haematol 2005;75:449-60.

Rosner MH, Dalkin AC. Electrolyte disorders associated with cancer. Adv Chronic Kidney Dis 2014;21:7-17.

Salahudeen AK, Ali N, George M, Lahoti A, Palla S. Tolvaptan in hospitalized cancer patients with hyponatremia: A double-blind, randomized, placebo-controlled clinical trial on efficacy and safety. Cancer 2014;120:744â€“751.

Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-60.

Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-76.

Faull R. Prescribing in renal disease. Aust Prescr 2007;30:17-20.

Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 2005;142:425-32.

HeikkilÃ¤ K, Ebrahim S, Rumley A, Lowe G, Lawlor DA. Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: Findings from the British Womenâ€™s Heart and Health Study. Cancer Epidemiol Biomarkers Prev 2007;16:1155-9.

Suzuki K, Ito Y, Wakai K, Kawado M, Hashimoto S, Seki N, et al. Serum heat shock protein 70 levels and lung cancer risk: A case-control study nested in a large cohort study. Cancer Epidemiol Biomarkers Prev 2006;15:1733-7.

Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: The Rotterdam Study. J Clin Oncol 2006;24:5216-22.

Weatherburn MW. Urease-Berthelot colorimetric method for in vitro determination of urea. Anal Chem S 1967;39:971.

Bartels H, BÃ¶hmer M, Heierli C. Serum creatinine determination without protein precipitation. Clin Chim Acta 1972;37:193-7.

AOAC. Official Methods of Analysis. 15th ed. Washington, DC: AOAC; 1990. p. 32-4.

Henry RJ, Cannon DC, Winkleman JK. Clinical Chemistry. Maryland, USA: Published by Harger and Row; 1974. p. 248-60.

Deraz TE, Kamel TB, El-Kerdany TA, El-Ghazoly HM. High-sensitivity C reactive protein as a biomarker for grading of childhood asthma in relation to clinical classification, induced sputum cellularity, and spirometry. Pediatr Pulmonol 2012;47:220-5.

Kuo HW, Chen SF, Wu CC, Chen DR, Lee JH. Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol Trace Elem Res 2002;89:1-11.

Milde D, Altmannova K, Vyslouzil K, Stuzka V. Trace element levels in blood serum and colon tissue in colorectal cancer. Clin J 2004;59:157-60.

Falconer IS, Slater C, Ross JA, Preston T, Fearon K. Albumin synthetic rates, the acute phase response and cyrolanes in pancreatic cancer. J Surg 1995;82:682.

Sharma J, Gupta S, Soni MM, Malakar M. Pathological outcome in the patients with different ailments: A comprehensive study in Lakhimpur district, Assam. Innov J Med Sci 2014;2:3-5.

Koji K, Shiro H, Mitsuo T, Hideyuki A. Serum creatinine level for cervical cancer.Jpn J Oncol 1998;28:546-50.

Christy M. Your Own Perfect Medicine. Scottsdale, Arizona: Future Medicine Inc.; 1994. p. 2.

Miller DC, Hafez KS, Stewart A, Montie JE, Wei JT. Prostate carcinoma presentation, diagnosis, and staging: An update form the National Cancer Data Base. Cancer 2003;98:1169-78.

Saad EA, Habib SA, Refai WA, Elfayoumy AA. Malondialdehyde, adiponectin, nitric oxide, C-reactive protein, tumor necrosis factor-alpha and insulin resistance relationships and inter-relationships in Type 2 diabetes early stage. Is metformin alone adequate in this stage? Int J Pharm Pharm Sci 2017;9:176-81.

Satayanarayana U, Chakrapani U. Cancer. In: Biochemistry. 4th ed. New York: Books and Allied Publishers Ltd.; 2013. p. 685-94.